WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 5'1401 Infant (under 12 months) mortality rate: 52
GDP / capita (US$): 13'9081 Child (under 5 years) mortality rate: 62

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 2'081  2'079  2'077  2'076  2'074  2'035  1'996  1'924 
Births 23  23  23  23  23  26  35  41 
Surviving infants 23  23  23  23  23  26  34  38 
Pop. less than 5 years 118  116  115  113  111  136  174  189 
Pop. less than 15 years 349  350  353  355  358  461  523  574 
Female 15-49 years 517  520  523  527  530  527  515  498 

Number of reported cases

(Click for retrospective incidence data for The former Yugoslav Republic of Macedonia)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  116  36 
Mumps
ChartChart
  45  52  60  97  441 
Pertussis
ChartChart
  21 
Polio*
ChartChart
 
Rubella
ChartChart
  87 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for The former Yugoslav Republic of Macedonia)
Vaccine year result method % card seen                                                
BCG 2009  98  MICS   89  99  94  99  97  95  97 
DTP1 2009  98  MICS   89  97  98  98  97  98  98 
DTP3 2009  95  MICS   89  95  91  95  98  95  95 
DTP4          89  91  93 
IPV1          97  98 
HepB_BD          98  99  98  99 
HepB3          94  92  97  97  98 
Hib3 2009  95  MICS   89  94  89  94  97  95 
JapEnc         
MCV1          82  89  93  96  96  97 
MCV2          93  93  96  96  96  95 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2009  97  MICS   89  95  92  96  98  97  96 
Rota1         
RotaC         
RCV1          82  89  93  96  96 
TT2plus         
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for The former Yugoslav Republic of Macedonia)
BCG
ChartChart
  99  94  99  97  95  97 
DTP1
ChartChart
  97  98  98  99  98  98 
DTP3
ChartChart
  95  91  95  98  95  95 
HepB3
ChartChart
  94  92  97  97  98 
HepB_BD
ChartChart
  98  98  98  98  99 
Hib3
ChartChart
  94  89  94  97  95 
IPV1
  97  98 
MCV1
ChartChart
  82  89  93  96  96  97 
MCV2
ChartChart
  93  93  96  96  96  95 
PCV3
 
Pol3
ChartChart
  95  92  96  98  97  96 
RCV1
ChartChart
  82  89  93  96  96  97 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 31  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 97
From 80 to 89% 3
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaPHibHepIPV 2, 6 months; Yes
DTaPHibIPV 3.5, 18 months; Yes
DTaPIPV From January 2019
DTwP 4 years; Yes
HepB_Pediatric birth; Yes
HPV 12 years; +6 months; Yes
Influenza_Adult > 64 years; Yes and adults with chronic diseases, pregnant women, health care workers and Haj and travelers
Influenza_Pediatric Yes Children with chronic diseases
MMR 12 months; 6 years; Yes
OPV 7, 14 years; Yes
Td 7, 14 years; Yes
TT 18 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  No   
What years does the MYP cover? number 2012-2020  2012-2020  2012-2020  2012-2020  2012-2020     
Nº of districts with microplans that include activities to raise immunization coverage number 31  31  31  31       

System performance

Total Nº districts in country number 31  31  31  31  31  31  31 
Nº districts with DTP3 coverage >=80% number 31  30  31  31  31  31  31 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  97  100  100  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 15  23  30  28  29  29 
% of districts with MCV1 coverage >=95% From 0 to 100% 26  48  74  97  90  94  94 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes    Yes  Yes  No  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%              

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR   Yes  Yes  Yes  Yes  Yes   

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.